Richard S. Greenberg - 27 Jan 2022 Form 4 Insider Report for NEXIEN BIOPHARMA, INC. (NXEN)

Signature
Richard S. Greenberg
Issuer symbol
NXEN
Transactions as of
27 Jan 2022
Net transactions value
$0
Form type
4
Filing time
31 Jan 2022, 14:56:10 UTC
Previous filing
29 Nov 2021
Next filing
15 Sep 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NXEN Common Stock Award +250,000 +6% 4,435,192 27 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NXEN Class A Warrant 1,062,953 27 Jan 2022 common stock 1,062,953 $0.0403 Direct
holding NXEN Class B Warrant 1,062,953 27 Jan 2022 common stock 1,062,953 $0.0433 Direct
holding NXEN Class C Warrant 1,062,953 27 Jan 2022 common stock 1,062,953 $0.0452 Direct
holding NXEN Convertible note 40,000 27 Jan 2022 common stock 1,062,953 $0.0376 Direct
holding NXEN Options to purchase common stock (right to buy) 150,000 27 Jan 2022 common stock 150,000 $0.5400 Direct
holding NXEN Options to purchase common stock (right to buy) 100,000 27 Jan 2022 common stock 100,000 $0.6550 Direct
holding NXEN Options to purchase common stock (right to buy) 2,500,000 27 Jan 2022 common stock 2,500,000 $0.0800 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Issued in lieu of compensation for services.